Viral packaging plasmids (pRSV-REV, pVSV-G, pMDL-g/p-RRE) were obtained from AddGene. ATG5 short hairpin RNA (shRNA) constructs (TRCN0000151963, TRCN0000151474, TRCN0000330392), ATG7 shRNA constructs (TRCN0000007586, TRCN0000007588, TRCN0000364479), Sigma1 shRNA constructs (TRCN0000296908, TRCN0000291305, TRCN0000061010, TRCN0000061008), and a nontargeting control shRNA construct (SCH002) were obtained from Sigma-Aldrich. The FLAG-AR and FLAG-ARV7 plasmid constructs were gifts from Dr. Stephen Plymate (University of Washington School of Medicine, Seattle, WA) and have been described elsewhere (58 (link)). pEGFP-LC3 was a gift from Drs. Grazia Ambrosini and Gary K. Schwartz [Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY] and has been described previously (56 (link)). Transient transfections were performed with jetPRIME transfection reagent (PolyPlus) according to manufacturer's procedures. LNCaP GFP-LC3 stable cell lines were generated using the pBABE-Puro-mCherry-EGFP-LC3B plasmid construct (Addgene 22418). Transfection was performed with jetOPTIMUS transfection reagent (PolyPlus) according to manufacturer's protocol. Cells were maintained in high-glucose RPMI (Corning) supplemented with 10% FBS (Corning) and 1 µg/mL puromycin (Thermo Fisher Scientific).
Free full text: Click here